Other approaches for MYC inhibition have been carried out using nanoparticles with anisamide-targeted MYC-specific siRNA to enter melanoma cells upon binding to a cell-specific sigma receptor using murine and human xenograft tumor models (167). The gene discussed is MYC; the disease is melanoma.